PTGS2 and neoplasm: In this context, the COX-2/PGE-2 pathway is an appealing target once its blockage can have protective effects by reducing cancer progression and immune evasion as well as sensitizing tumor cells to apoptogenic therapies, such as chemotherapy and radiotherapy (16, 18–21).